Parniak, Michael A.

Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication

Li, X., Mak, J., Arts, E. J., Gu, Z., Kleiman, L., Wainberg, M. A., & Parniak, M. A. (1994) · Journal of Virology

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 118

Design, synthesis, and biological evaluations of hydroxypyridonecarboxylic acids as inhibitors of HIV reverse transcriptase associated RNase H

Kankanala, J., Kirby, K. A., Liu, F., Miller, L., Nagy, E., Wilson, D. J., Parniak, M. A., Sarafianos, S. G., & Wang, Z. (2016) · Journal of Medicinal Chemistry

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 66

Physicochemical and Biochemical Properties of 2‘,5‘-Linked RNA and 2‘,5‘-RNA:3‘,5‘-RNA “Hybrid” Duplexes,

Wasner, M., Arion, D., Borkow, G., Noronha, A., Uddin, A. H., Parniak, M. A., & Damha, M. J. (1998) · Biochemistry

DNA and Nucleic Acid ChemistryRNA and protein synthesis mechanisms

Cited by 61

Inhibitors of HIV-1 Reverse Transcriptase—Associated Ribonuclease H Activity

Ilina, T., LaBarge, K., Sarafianos, S. G., Ishima, R., & Parniak, M. A. (2012) · Biology

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 54

6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity

Wang, L., Tang, J., Huber, A. D., Casey, M. C., Kirby, K. A., Wilson, D. J., Kankanala, J., Xie, J., Parniak, M. A., Sarafianos, S. G., et al. (2018) · European Journal of Medicinal Chemistry

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 36